Technical View
STI, Biosensors, Chartered Semiconductor
Straits Times Index: Expect some respite for the week

| Significance |
Price |
Details |
| 2ndResistance |
2,686 – 2,706 |
Technical gap |
| 1st Resistance |
2,585 – 2,626 |
Technical gap / Lower Bollinger Band |
| Current level |
2,574.21 |
Closing price of FSSTI on 05 Sep 08 |
| Support level |
2,554 |
Daily low on 05 Sep |
Expectations that the 2,660 level would hold for the Straits Times Index (FSSTI Index) were not met as market
sentiment took on a very bearish tone during the later part of the previous week. After losing 165 points in Sep 08 so far,
the 14-day RSI is now trading below the 30 mark, an indication that the STI is oversold. We note that although that the
STI has plunged 26% (or 908 points) for the year, the RSI has only depicted eight instances of being oversold. Out of
these eight instances, we also note that the STI has always managed to stage a rebound within the following week after
the RSI hits below the 30 reading.
While it is debatable as to whether this potential rebound may fizzle out, we are at least expecting the STI to post some
gains for the current week. Support is seen at the 2,554 level while initial resistance is identified at the 2,585 – 2,626
area as defined by the technical gap and the lower bollinger band. Further resistance is available at the 2,686 – 2,706
range, courtesy of another technical gap.
Biosensors: Downtrend may have ended

| Significance |
Price |
Details |
| 2nd Resistance |
0.605 – 0.615 |
Technical gap |
| 1st Resistance |
0.555 |
50-day MA / Daily high on 04 Sep |
| Current level |
0.52 |
Closing price of BIG on 05 Sep 08 |
| Support level |
0.495 – 0.505 |
Lower Bollinger Band / Daily lows on 30 & 31 Jul, 01 Aug and 05 Sep |
In an earlier report, we mentioned that the rally Biosensors (BIG SP) had been experiencing was losing steam. After
hitting our former resistance level at the 0.645 mark, share price then began losing ground as it closed at 0.52 during
the end of the previous week. We now believe that the correction period is already over and that price action is poised
to recover.
The 14-day ADX has started turning downwards, an indication that the present downtrend is weak. Furthermore, share
price had rebounded nicely after it had touched the lower bollinger band at the 0.505 mark and we have identified this
as part of our 0.495 – 0.505 support level. Meanwhile, should this current rebound continue, initial resistance residing at
the 0.555 level may cap further upside. In the event that this barrier is broken, the 2nd resistance is seen at the 0.605 –
0.615 area as derived from the technical gap.
Chartered Semiconductor: Grossly oversold, rebound is forthcoming

| Significance |
Price |
Details |
| 2nd Resistance |
0.49 |
Daily high on 01 Sep |
| 1st Resistance |
0.43 |
Daily high on 02 Sep |
| Current level |
0.405 |
Closing price of CSM on 05 Sep 08 |
| Support level |
0.395 |
All-time low on 05 Sep / Lower Bollinger Band |
Chartered Semiconductor (CSM SP) reached its all-time low on 05 Sep with its 14-day RSI coming in slightly above a
reading of 10, strongly suggestive that the underlying security is way oversold. More importantly, the RSI is currently
depicting a positive divergence relative to its share price, an indication that the selling pressure may be coming off.
Furthermore, we also note that ever since price action had produced a spike down on 01 Sep, trading volume has been
tapering off, signifying that the present downtrend may be losing strength.
We believe that a technical rebound should be forthcoming – resistance levels are identified at 0.43 and 0.49, courtesy
of their respective daily highs. Meanwhile, support at the 0.395 level as depicted by the lower bollinger band and the alltime
low on 05 Sep should be able to keep any additional downside in check.
DMG & Partners Research Guide to Investment Ratings
Buy: Share price may exceed 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
-----------------------------------------------------------------------------------------------------------------------------------------------
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Take Profit: Target price has been attained. Look to accumulate at lower levels
-----------------------------------------------------------------------------------------------------------------------------------------------
Sell: Share price may fall by more than 10% over the next 12 months
-----------------------------------------------------------------------------------------------------------------------------------------------
Not Rated: Stock is not within regular research coverage
This research is for general distribution. It does not have any regard to the specific investment objectives, financial situation and particular needs of
any specific recipient of this research report. You should independently evaluate particular investments and consult an independent financial adviser
before making any investments or entering into any transaction in relation to any securities or investment instruments mentioned in this report.
The information contained herein has been obtained from sources we believed to be reliable but we do not make any representation or warranty nor accept any responsibility or liability as to its accuracy, completeness or correctness. Opinions and views expressed in this report are subject to
change without notice.
This report does not constitute or form part of any offer or solicitation of any offer to buy or sell any securities, DMGAPS and its affiliates, their directors, connected person and employees may from time to time have interest and/or underwriting commitment in the securities mentioned in this
report.
DMG & Partners Securities Pte Ltd is a participant in the SGX-MAS Research Incentive Scheme and receives a compensation of S$5,000 per stock per annum covered under the Scheme.
DMG & Partners Securities Pte Ltd is a joint venture between OSK Securities Berhad (a subsidiary of OSK Investment Bank Berhad) and Deutsche Asia Pacific Holdings Pte Ltd (a subsidiary of Deutsche Bank Group). DMG & Partners Securities Pte Ltd is a Member of the Singapore Exchange Securities Trading Limited. |